Gene therapy for hemophilia marks a groundbreaking advancement in the treatment of this challenging condition, providing hope for patients like Terence Blue, who have managed the complexities of hemophilia B for decades.Through innovative approaches such as Hemgenix gene therapy, developed by CSL Behring, patients may experience significant reductions in their reliance on traditional clotting factor IX injections.